Metabolism of trichloroethylene

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 177-200

  Lash, Lawrence H ^a   Fisher, Jeffrey W ^b   Lipscomb, John C ^c   Parker, Jean C ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Conjugate beta lyase; Cysteine glutathione; Cytochrome P450; Glutathione S transferases; Metabolism; Sex dependence; Species dependence; Tissue dependence trichloroethylene

Indexed keywords

CHLORAL HYDRATE; CYSTEINE CONJUGATE BETA LYASE; CYTOCHROME P450; DICHLOROACETIC ACID; GLUTATHIONE; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; GLUTATHIONE METABOLISM; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; MALE; METABOLITE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; TARGET ORGAN; TISSUE DISTRIBUTION; TOXICOKINETICS;

ANIMALIA;

EID: 0033919417     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2177     Document Type: Article

References (168)

1. Wu C, Beeker J, Schaum J. Major findings of the exposure assessment of trichloroethylene and related compounds. Environ Health Perspect 108(supp 2):359-358 (2000).
2. Clewell HJ III, Gentry PR, Covington TR, Gearhart JM. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(suppl 2):283-305 (2000).
3. Sato A, Nakajima T. Differences following skin or inhalation exposure in the absorption and excretion kinetics of trichloroethylene and toluene. Br J Ind Med 35:43-49 (1978).
4. Davidson IWF, Beliles RP. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev 23:493-599 (1991).
5. Bogen KT, Colston BW Jr, Machicao LK. Dermal absorption of dilute aqueous chloroform, trichloroethylene, and tetrachloroethylene in hairless guinea pigs. Fundam Appl Toxicol 18:30-39 (1992).
6. Withey JR, Collins BT, Collins PG. Effect of vehicle on the pharmacokinetics and uptake of four halogenated hydrocarbons from the gastrointestinal tract of the rat. J Appl Toxicol 3:249-253 (1983).
7. Prout MS, Provan WM, Green T. Species differences in response to trichloroethylene. I: Pharmacokinetics in rats and mice. Toxicol Appl Pharmacol 79:389-400 (1985).
8. Fisher JW, Gargas ML, Allen BC, Andersen ME. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol Appl Pharmacol 109:183-195 (1991).
9. Bull RJ. Mode of action of liver tumor induction by trichloroethylene. Environ Health Perspect 108(supp 2):241-259(2000).
10. Dallas CE, Gallo JM, Ramanathan R, Muralidhara S, Bruckner JV. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. Toxicol Appl Pharmacol 110:303-314 (1991).
11. Lipscomb JC, Fisher JW, Confer PD, Byczkowski JZ. In vitro to in vivo extrapolation for trichloroethylene metabolism. Toxicol Appl Pharmacol 152:376-387 (1998).
12. 36Cl-labeled trichloroethylene and tetrachloroethylene in the rat. Biochem Pharmacol 12:795-802 (1963).
13. Dekant W, Metzler M, Henschler D. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem Pharmacol 33:2021-2027 (1984).
14. D'Souza RW, Bruckner JV, Feldman S. Oral and intravenous trichloroethylene pharmacokinetics in the rat. J Toxicol Environ Health 15:587-601 (1985).
15. Lee K, Bruckner JV, Muralidhara S, Gallo JM. Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats. Toxicol Appl Pharmacol 139:262-271 (1996).
16. Kleinfeld M, Tabershaw IR. Trichloroethylene toxicity: report of five fatal cases. Arch Ind Hyg Occup Med 10:134-141 (1954).
17. Brüning T, Vamvakas S, Makropoulos V, Birner G. Acute intoxication with trichloroethene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol Sci 41:157-165 (1998).
18. Allen BC, Fisher JW. Modeling of the pharmacokinetics of trichloroethylene and trichloroacetic acid in humans. Risk Anal 13:71-86 (1993).
19. Fisher JW, Mahle D, Abbas R. A human physiologically-based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol Appl Pharmacol 152:339-359 (1998).
20. Fisher JW, Whittaker TA, Taylor DH, Clewell HJ III, Andersen ME. Physiologically-based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol Appl Pharmacol 99:395-414 (1989).
21. Müller G, Spassovski M, Henschler D. Trichloroethylene exposure and trichloroethylene metabolites in urine and blood. Arch Toxicol 29:335-340 (1972).
22. Abbas R, Fisher JW. A physiologically-based pharmacokinetic model for trichloroethylene and its metabolites, chloralihydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol Appl Pharmacol 147:15-30 (1997).
23. Anders MW, Jakobson I. Biotransformation of halogenated solvents. Scand J Work Environ Health 11(suppl 1):23-32 (1985).
24. Butler TC. Metabolic transformations of trichloroethylene. J Pharmacol Exp Ther 97:84-92 (1949).
25. Powell JF. Trichloroethylene: absorption, elimination and metabolism. Br J Ind Med 2:142-145 (1945).
26. Miller RE, Guengerich FP. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097 (1982).
27. Miller RE, Guengerich FP. Metabolism of trichloroethylene in isolated hepatocyles, microsomes, and reconstituted systems containing cytochrome P-450. Cancer Res 43:1145-1152 (1983).
28. Green T, Prout MS. Species differences in response to trichloroethylene. II: Biotransformation in rats and mice. Toxicol Appl Pharmacol 79:401-411 (1985).
29. Dowsley TF, Ulreich JB, Bolton JL, Park SS, Forkert PG. CYP2E1-dependent bioactivation of 1,1-dichloroethylene in murine lung: formation of reactive intermediates and glutathione conjugates. Toxicol Appl Pharmacol 139:42-48 (1996).
30. Forkert PG. In vivo formation and localization of 1,1-dichloroethylene epoxide in murine liver: identification of its glutathione conjugate 2-S-glutathionyl acetate. J Pharmacol Exp Ther 290:1299-1306 (1999).
31. Forkert PG. 1,1-Dichloroethylene-induced Clara cell damage is associated with in situ formation of the reactive epoxide. Immunohistochemical detection of its glutathione conjugate. Am J Respir Cell Mol Biol 20:1310-1318 (1999).
32. Forkert PG, Malkinson AM, Rice P, Moussa M. Diminished CYP2E1 expression and formation of 2-S-glutathionyl acetate, a glutathione conjugate derived from 1,1-dichloroethylene epoxide, in murine lung tumors. Drug Metab Dispos 27:68-73 (1999).
33. U.S. EPA. Health Assessment Document for Trichloroethylene. Final Report. Office of Health and Environmental Assessment. EPA/600/8-82-006F, Washington, DC:U.S. Environmental Protection Agency, 1985.
34. Goeptar AR, Commandeur JNM, van Ommen B, van Bladeren PJ, Vermeulen NPE. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem Res Toxicol 8:3-21 (1995).
35. Guengerich FP. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391-407 (1991).
36. Guengerich FP, Kim D-H, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179 (1991).
37. Koop DR, Crump BL, Nordblom GD, Coon MJ. Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proc Natl Acad Sci USA 82:4065-4069 (1985).
38. Nakajima T, Okino T, Okuyama S, Kaneko T, Yonekura I, Sato A. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. Toxicol Appl Pharmacol 94:227-237 (1988).
39. Nakajima T, Wang R-S, Murayama N, Sato A. Three forms of trichloroethylene-metabolizing enzymes in rat liver induced by ethanol, phenobarbital, and 3-methylcholanthrene. Toxico. Appl Pharmacol 102:546-552 (1990).
40. Nakajima T, Wang R-S, Elovaara R, Park SS, Gelboin HV, Vainio H. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem Pharmacol 43:251-257 (1992).
41. Nakajima T, Wang R-S, Katakura V, Kishi R, Elovaara E, Park SS, Gelboin HV, Vainio H. Sex-, age-and pregnancy-induced changes in metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J Pharmacol Exp Ther 261:869-874 (1992).
42. Nakajima T, Wang R-S, Elovaara E, Park SS, Gelboin HV, Vainio H. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes. Biochem Pharmacol 45:1079-1085 (1993).
43. Forkert PG, Birch DW. Pulmonary toxicity of trichloroethylene in mice: covalent binding and morphological manifestations. Drug Metab Dispos 17:106-113 (1989).
44. Green T, Mainwaring GW, Foster JR. Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species. Fundam Appl Toxicol 37:125-130 (1997).
45. Odum J, Foster JR, Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem-Biol Interact 83:135-153 (1992).
46. Abbas R, Seckel CS, Kidney JK, Fisher JW. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab Dispos 24:1340-1346 (1996).
47. Larson LJ, Bull RJ. Effect of ethanol on the metabolism of trichloroethylene. J Toxicol Environ Health 28:395-406 (1989).
48. Müller S, Spassovski M, Henschler D. Metabolism of trichloroethylene in man. III: Interaction of trichloroethylene and ethanol. Arch Toxicol 33:173-189 (1975).
49. Ni Y-C, Wong T-Y, Lloyd RV, Heinze TM, Shelton S, Casciano D, Kadlubar FF, Fu PP. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab Dispos 24:81-90 (1996).
50. Schultz J, Weiner H. Alteration of the enzymology of chloral hydrate reduction in the presence of ethanol. Biochem Pharmacol 28:3379-3384 (1979).
51. Sellers EM, Lang M, Koch-Weser J, LeBlanc E, Kalant H. Interaction of chloral hydrate and ethanol in man. I: Metabolism. Clin Pharmacol Ther 13:37-49 (1972).
52. Lipscomb JC, Mahle DA, Brashear WT, Garrett CM. A species comparison of chloral hydrate metabolism in blood and liver. Biochem Biophys Res Commun 227:340-350 (1996).
53. Dekant W, Schulz A, Metzler M, Henschler D. Absorption, elimination and metabolism of trichloroethylene: a quantitative comparison between rats and mice. Xenobiotica 16:143-152 (1986).
54. Larson JL, Bull R.J. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol 115:278-285 (1992).
55. Templin MV, Stevens DK, Stenner RD, Bonate PL, Tuman D, Bull RJ. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J Toxicol Environ Health 44:435-447 (1995).
56. Larson JL, Bull RJ. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115:268-277 (1992).
57. Templin MV, Parker JC, Bull RJ. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol Appl Pharmacol 123:1-8 (1993). [Erratum published in Toxicol Appl Pharmacol 133:177 (1995)]
58. Ketcha MM, Stevens DK, Warren DA, Bishop CT, Brashear WT. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J Anal Toxicol 20:236-241 (1996).
59. Henderson GN, Yan Z, James MO, Davydova N, Stacpoole PW. Kinetics and metabolism of chloral hydrate in children: Identification of dichloroacetate as a metabolite. Biochem Biophys Res Commun 235:695-698 (1997).
60. Lipscomb JC, Mahle DA, Brashear WT, Barton HA. Dichloroacetic acid: metabolism in cytosol. Drug Metab Dispos 23:1202-1205 (1995).
61. James MO, Cornett R, Yan Z, Henderson GN, Stacpoole PW. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats. Drug Metab Dispos 25:1223-1227 (1997).
62. Tong Z, Board P, Anders MW. Glutathione transferase zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J 331:371-374 (1998).
63. Cummings BS, Putt DW, Parker JC, Lash LH. Unpublished data.
64. Lipscomb JC, Garrett CM, Snawder JE. Cytochrome P450 dependent metabolism of trichloroethylene: interindividual differences in humans. Toxicol Appl Pharmacol 142:311-319 (1997).
65. Wrighton SA, Stevers JC. The human hepatic cytochromes P450 involved in drug metabolism. CRC Crit Rev Toxicol 22:1-21 (1992).
66. Lipscomb JC, Garrett CM, Snawder JE. Use of kinetic and mechanistic data in species extrapolation of bioactivation: cytochrome P-450 dependent trichloroethylene metabolism at occupationally relevant concentrations. J Occup Health 43:110-117 (1998).
67. Moghaddam AP, Abbas R, Fisher JW, Stavrou S, Lipscomb JC. Metabolism of trichioroacetic acid to dichloroacetic acid by rat and mouse gut microflora, an in vitro study. Biochem Biophys Res Commun 228:639-645 (1996).
68. Moghaddam AP, Abbas R, Fisher JW, Lipscomb JC. Role of mouse intestinal microflora in dichloroacetic acid formation, an in vivo study. Human Exp Toxicol 16:629-635 (1997).
69. Maiorino RM, Gandolfi AJ, Sipes IG. Gas chromatographic method for the halothane metabolites, trifluoroacetic acid and bromide, in biological fluids. Anal Toxicol 4:250-254 (1980).
70. Elfarra AA, Krause RJ, Last LR, Lash LH, Parker JC. Species-and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes. Drug Metab Dispos 26:779-785 (1998).
71. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 3:566-573 (1990).
72. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals. Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423 (1994).
73. Barton HA, Flemming CD, Lipscomb JC. Evaluating human variability in chemical risk assessment hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology 110:271-287 (1996).
74. Lindahl R, Evces S. Comparative subcellular distribution of aldehyde dehydrogenase in rat, mouse and rabbit liver. Biochem Pharmacol 33:3383-3389 (1984).
75. Badawy AA, Aliyu SU. Antagonism of acute alcohol intoxication by naloxone. Alcohol 19:199-201 (1984).
76. Lipscomb JC. Unpublished data
77. Sellers EM, Lang-Sellers M, Koch-Weser J. Comparative metabolism of chloral hydrate and trichlofos. J Clin Pharmacol 18:457-461 (1978).
78. Pravecek TL, Channel SR, Schmidt WJ, Kidney JK. Cytotoxicity and metabolism of dichloroacetic acid and trichloroacetic acid in B6C3F1 mouse liver tissue. In Vitro Toxicology 9:261-269 (1996).
79. Kawamoto T, Hobara T, Aoki T, Kobayashi H, Iwamoto S, Sakai T, Miyazaki Y, Imamura A, Ogino K. Metabolism of chloral hydrate in the anoxic perfused liver. Toxicol Lett 40:225-231 (1988).
80. Wang GZ, Takano T, Tomita T, Nakata K, Nakamura K. Interaction of trichloroethylene and isopropyl alcohol in the perfused rat liver. Nippon Eiseigaku Zasshi 48:1000-1005 (1993).
81. Reitz RH, Garagas ML, Mendrala AL, Schumann AM. In vivo and in vitro studies of perchloroethylene metabolism for physiologically-based pharmacokinetic modeling in rats, mice and humans. Toxicol Appl Pharmacol 136:289-306 (1996).
82. McKinney LL, Weakley FB, Eldridge AC, Campbell RG, Cowan JC, Beister HW. S-(Dichloroninyl)-t-cysteine: an agent causing fatal aplastic anemia in calves. J Am Chem Soc 79:3932-3933 (1957).
83. McKinney LL, Picken JC, Weakley FB, Eldridge AC, Campbell RG, Cowan JC, Beister HE. Possible toxic factor of trichloroethylene-extracted soybean oil. J Am Chem Soc 81:909-915 (1959).
84. Dekant W, Metzler M, Henschler D. Identification of S-(1,2-dichlorovinyl)-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. Biochem Pharmacol 35:2455-2458 (1986).
85. Elfarra AA, Anders MW. Renal processing of glutathione conjugates: role in nephrotoxicity. Biochem Pharmacol 33:3729-3732 (1984).
86. Elfarra AA, Jakobson I, Anders MW. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem Pharmacol 35:283-288 (1986).
87. Dekant W, Koob M, Henschler D. Metabolism of trichloroethene - In vivo and in vitro evidence for activation by glutathione conjugation. Chem-Biol Interact 73:89-101 (1990).
88. Lash LH, Putt DA, Brashear WT, Abbas R, Parker JC, Fisher JW. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J Toxicol Environ Health 56:1-21 (1999).
89. Lash LH, Parker JC, Scott CS. Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108(suppl 2):225-240 (2000).
90. Lash LH, Jones DP, Anders MW. Glutathione homeostasis and glutathione S-conjugate toxicity in kidney. Rev Biochem Toxicol 9:29-67 (1988).
91. Lash LH, Anders MW. Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem 261:13076-1308 (1986).
92. Duffel MW, Jakoby WB. Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes. Mol Pharmacol 21:444-448 (1982).
93. Wolfgang GH, Gandclfi AJ, Stevens JL, Brendel K. N-Acetyl-S-(1,2-dichlorovinyl]-L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices: differential transport and metabolism. Toxico Appl Pharmacol 101:205-219 (1989).
94. Zhang G, Stevens JL. Transport and activation of S-(1,2-dichlorovinyl)-L-cysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol Appl Pharmacol 100:51-61 (1989).
95. Commandeur JNM, Vermeulen NPE. Identification of N-acetyl(2,2-dichlorovinyli-and N-acetyl(1,2-dichloravinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in the rat. Chem Res Toxicol 3:212-218 (1990).
96. Bernauer U, Birner G, Dekant W, Henschler D. Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch Toxicol 70:338-346 (1996).
97. Birner G, Vamvakas S, Dekant W, Henschler D. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: implications for the risk of trichloroethene exposure. Environ Health Perspect 99:281-284 (1993).
98. Anderson PM, Schulte MO. Cleavage of S-(1,2-dichlorovinyl)-L-cysteine by and enzyme of bovine origin. Arch Biochem Biophys 111:593-602 (1965).
99. Dohn DR, Anders MW. Assay of cysteine conjugate β-lyase activity with S-(2-benzothiazolyl)cysteine as the substrate. Anal Biochem 120:379-386 (1982).
100. Stevens JL. Isolation and characterization of a rat liver enzyme with both cysteine conjugate β-lyase and kynureninase activity. J Biol Chem 260:7945-7950 (1985).
101. Stevens J, Jakoby WB. Cysteine conjugate β-lyase. Mol Pharmacol 23:761-765 (1983).
102. Tateishi M, Suzuki S, Shimizu H. Cysteine conjugate β-lyase in rat liver: a novel enzyme catalyzing formation of thiol-containing metabolites of drugs. J Biol Chem 253:8854-8859 (1978).
103. Tomisawa H, Ichihara S, Fukazawa H, Ichimoto N, Tateishi M, Yamamoto I. Purification and characterization of human hepatic cysteine conjugate β-lyase. Biochem J 235:569-575 (1986).
104. Larsen GL, Stevens JL. Cysteine conjugate β-lyase in the gastrointestinal bacterium Eubacterium limosum. Mol Pharmacol 29:97-103 (1986).
105. Tomisawa H, Suzuki S, Ichihara S, Fukazawa H, Tateishi M. Purification and characterization of C-S lyase fron Fusobacterium varium: A C-S cleavage enzyme of cysteine conjugates and some S-containing amino acids. J Biol Chem 259:2588-2593 (1984).
106. Alberati-Giani D, Malherbe P, Köhler C, Lang G, Kiefer V, Lahm H-W, Cesura AM. Cloning and characterization of a soluble kynurenine aminotransferase from rat brain, identity with kidney cysteine conjugate β-lyase. J Neurochem 64:1448-1455 (1995).
107. Malherbe P, Alberati-Giani D, Köhler C, Cesura AM. Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett 367:141-144 (1995).
108. Stevens JL. Cysteine conjugate β-lyase activities in rat kidney cortex: subcellular localization and relationship to the hepatic enzyme. Biochem Biophys Res Commun 129:499-504 (1985).
109. Abraham DG, Cooper AJL. Glutamine transaminase K and cysteine S-conjugate β-lyase activity stains. Anal Biochem 197:421-427 (1991).
110. Elfarra AA, Lash LH. Anders MW, α-Ketoacids stimulate rat renal cysteine conjugate β-lyase activity and potentiate the cytotoxicity of S-[1,2-dichlorovinyl)-L-cysteine. Mol Pharmacol 31:208-212 (1987).
111. Jones TW, Qin C, Schaeffer VH, Stevens JL. Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate β-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity. Mol Pharmacol 34:621-627 (1988).
112. Lash LH, Elfarra AA, Anders MW. Renal cysteine conjugate β-lyase: bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. J Biol Chem 261:5930-5935 (1986).
113. Lash LH, Nelson RM, Van Dyke RA, Anders MW. Purification and characterization of human kidney cysteine conjugate β-lyase activity. Drug Metab Dispos 18:50-54 (1990).
114. Perry SJ, Schofield MA, MacFarlane M, Lock EA, King LJ Gibson GG, Goldfarb PS. Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate β-lyase. Mol Pharmacol 43:660-665 (1993).
115. Stevens JL, Robbins JD, Byrd RA. A purified cysteine conjugate β-lyase from rat kidney cytosol: requirement for an α-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transamirase K. J Biol Chem 261:15529-15537 (1986).
116. Stevens JL, Avoubi N, Robbins JD. The role of mitochondrial matrix enzymes in the metabolism and toxicity of cysteine conjugates. J Biol Chem 263:3395-3401 (1988).
117. Abraham DG, Thomas RJ, Cooper AJL. Glutamine transaminase K is not a major cysteine S-conjugate β-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role. Mol Pharmacol 48:855-860 (1995).
118. 4. J Biol Chem 270:180-188 (1995).
119. Dekant W, Berthold K, Vamvakas S, Henschler D, Anders MW, Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate β-lyase. Chem Res Toxicol 1:175-178 (1988).
120. Dekant W, Lash LH, Anders MW. Bioactivation of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine. Proc Natl Acad Sci USA 84:7443-7447 (1987).
121. Dekant W, Urban G, Görsmann C, Anders MW. Thioketene formation from α-haloalkenyl 2-nitrophenyl disulfides: models for biological reactive intermediates of cytotoxic cysteine S-conjugates. J Am Chem Soc 113:5120-5122 (1991).
122. Eyre RJ, Stevens DK, Parker JC, Bull RJ. Renal activation of trichloroethene and S-(1,2-dichlorovinyl)-L-cysteine and cell proliferative responses in the kidneys of F344 rats and B6C3F1 mice. J Toxicol Environ Health 46:465-481 (1995).
123. Eyre RJ, Stevens DK, Pate JC, Bull RJ. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethene metabolism. J Toxicol Environ Health 46:443-464 (1995).
124. MacFarlane M, Schofield M, Parker N, Roelandt L, David M, Lock EA, King LJ, Goldfarb PS, Gibson GG. Dose-dependent induction or depression of cysteine conjugate β-lyase in rat kidney by N-acetyl-S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-L-cysteine. Toxicology 77:133-144 (1993).
125. Iyer RA, Frink EJ Jr, Eber: TJ, Anders MW. Cysteine conjugate β-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Anesthesiology 88:611-618 (1998).
126. Lash LH, Elfarra AA, Rakiewicz-Nemeth D, Anders MW. Bioactivation mechanism of cytotoxic homocysteine S-conjugates. Arch Biochem Biophys 276:322-330 (1990).
127. Stevens JL, Hatzinger PB, Hayden PJ. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of .-α-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate β-lyase. Drug Metab Dispos 17:297-303 (1989).
128. Sausen PJ, Elfarra AA. Cysteine conjugate S-oxidase: characterization of a novel enzymatic activity in rat hepatic and renal microsomes. J Biol Chem 265:6139-6145 (1990).
129. Sausen PJ, Duescher RJ, Elfarra AA. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol Pharmacol 43:388-396 (1993).
130. Ripp SL, Overby LH, Philpot RM, Elfarra AA. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing monooxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Mol Pharmacol 51:507-515 (1997).
131. Sausen PJ, Elfarra AA. Reactivity of cysteine S-conjugate sulfoxides: Formation of S-[1-chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem Res Toxicol 4:655-660 (1991).
132. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA. Role of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: Studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 269:374-383 (1994).
133. Werner M, Birner G, Dekant W. Sulfoxidation of mercapturic acids derived from tri-and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate β-lyase mediated cleavage. Chem Res Toxicol 9:41-49 (1996).
134. Bakke J, Gustafsson J-A. Mercapturic acid pathway metabolites of xenobiotics: generation of potentially toxic metabolites during enterohepatic circulation. Trends Pharmacol Sci 5:517-521 (1984).
135. Griffith OW, Meister A. Translocation of intracellular glutathione to membrane-bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc Natl Acad Sci USA 76:268-272 (1979).
136. Inoue M, Morino Y. Direct evidence for the role of the membrane potential in glutathione transport by renal brush-border membrane vesicles. J Biol Chem 260:326-331 (1985).
137. Akerboom TPM, Narayanaswami V, Kunst M, Sies H. ATP-dependertt S-(2,4-dinitrophenyl)glutathione transport in canalicular plasma membrane vesicles from rat liver. J Biol Chem 266:13147-13152 (1991).
138. Inoue M, Akerboom TPM, Sies H, Kinne R, Thao T, Arias IM. Biliary transport of glutathione S-conjugate by rat liver canalicular membrane vesicles. J Biol Chem 259:4998-5002 (1984).
139. Kobayashi K, Sogame Y, Hara H, Hayashi K. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J Biol Chem 265:7737-7741 (1990).
140. Niinuma K, Takenaka O, Horie T, Kobayashi K, Kato Y, Suzuki H, Sugiyama Y. Kinetic analysis of the primary active transport of conjugates metabolites across the bile canalicular membrane: Comparative study of S-(2,4-dinitrophenyl) glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothazole glucuronide. J Pharmacol Exp Ther 282:866-872 (1997).
141. Olive C, Board P. Glutathione S-conjugate transport by cultured human cells. Biochim Biophys Acta 1224:264-258 (1994).
142. Lash LH, Jones DP. Uptake of the glutathione conjugate S-(1,2-dichlorovinyl)glutathione by renal basal-lateral membrane vesicles and isolated kidney cells. Mol Pharmacol 28:278-282 (1985).
143. Lash LH, Jones DP. Transport of glutathione by renal basal-lateral membrane vesicles. Biochem Biophys Res Commun 112:55-60 (1983).
144. Lash LH, Jones DP. Renal glutathione transport: characteristics of the sodium-dependent system in the basal-lateral membrane. J Biol Chem 259:14508-14514 (1984).
145. Lash LH, Putt DA. Renal cellular transpon of exogenous glutathione: heterogeneity at physiological and pharmacological concentrations. Biochem Pharmacol 58:897-907 (1999).
146. Simmons TW, Anders MW, Ballatori N. L-Cysteine and S-(1,2-dichlorovinyl)-L-cysteine transport in rat liver canalicular membrane vesicles. potential reabsorption mechanisms for biliary metabolites of glutathione and its S-conjugates. J Pharmacol Exp Ther 262:1182-1188 (1992).
147. Schaeffer VH, Stevens JL. Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles. Mol Pharmacol 32:293-298 (1987).
148. Wright SH, Wunz TM, North J, Stevens JL. Na-Dependent transport of S-(1,2-dichlorovinyl)-L-cysteine by renal brush-border membrane vesicles. J Pharmacol Exp Ther 285:162-169 (1998).
149. Dantzler WH, Evans KK, Wright SH. Kinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules. J Pharmacol Exp Ther 272:663-672 (1998).
150. Lash LH, Anders MW. Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells. J Pharmacol Exp Ther 248:531-537 (1989).
151. Lash LH, Xu Y, Elfarra AA, Duescher RJ, Parker JC. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab Dispos 23:846-853 (1995).
152. Koob M, Dekant W. Metabolism of hexafluoropropene: evidence for bioactivation by glutathione conjugate formation in the kidney. Drug Metab Dispos 18:911-916 (1990).
153. Lash LH, Qian W, Putt DA, Jacobs K, Elfana AA, Krause RJ, Parker JC. Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences. Drug Metab Dispos 26:12-19 (1998).
154. Green T, Dow J, Ellis MK, Foster JR, Odum J. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem-Biol Interact 105:99-117 (1997).
155. Lash LH, Lipscomb JC, Putt DA, Parker JC. Glutathione conjugation of trichloroethylene in human liver and kidney: kinetics and individual variation. Drug Metab Dispos 27:351-359 (1999).
156. Hinchman CA, Ballatori N. Glutathione-degrading capacities of liver and kidney in different species. Biochem Pharmacol 40:1131-1135 (1990).
157. Green T, Odum J, Nash JA, Foster JR. Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans. Toxicol Appl Pharmacol 103:77-89 (1990).
158. Elfarra AA, Hwang IY. In vivo metabolites of S-(2-benzothiazolyl)-L-cysteine as markers of in vivo cysteine conjugate β-lyase and thiol glucuronosyl transferase activities. Drug Metab Dispos 18:917-922 (1990).
159. Lau SS, Kleiner HE, Monks TJ. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotox city. Drug Metab Dispos 23:1136-1142 (1995).
160. Carlile DJ, Zomorodi K, Houston JB. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver. Drug Metab Dispos 25:903-911 (1997).
161. Kedderis GL. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem-Biol Interact 107:109-121 (1997).
162. Brüning T, Lammert M, Kempkes M, Their R, Golka K, Bolt HM. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol 71:596-599 (1997).
163. Sato A, Nakajima T, Fujiwara Y, Murayama N. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after inhalation exposure. Br J Ind Med 34:55-63 (1977).
164. Clewell HJ III, Gentry PR, Gearhart JM, Allen BC, Covington TR, Andersen ME. Applying mechanistic information, pharmacokinetic modeling and margin of exposure evaluations in a novel risk assessment for trichloroethylene and its active carcinogenic metabolites: chloral hydrate, trichloroacetic acid, dichloroacetic acid, and dichlorovinylcysteine. Document prepared for OSHA Directorate of Health Standards Programs and U.S. Environmental Protection Agency Office of Health and Environmental Assessment, 1995.
165. Lipscomb JC, Mahle DA, Butler GW, Brashear WT. Unpublished data.
166. Banki K, Elfarra AA, Lash LH, Anders MW. Metabolism of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine to hydrogen sulfide and the role of hydrogen sulfide in S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine-induced mitochondrial toxicity. Biochem Biophys Res Commun 138:707-713 (1985).
167. MacFarlane M, Foster JR, Gibson GG, King LJ, Lock EA. Cysteine conjugate β-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicity. Toxicol Appl Pharmacol 98:185-197 (1989).
168. E-(trichloroacetyl)-L-lysine as protein adducts. Chem Res Toxicol 7:724-732 (1994).